Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yestar Healthcare Holdings Company Limited

巨 星 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2393)

US$200 MILLION 6.9% SENIOR NOTES DUE 2021

(Stock Code: 4508)

SUSPENSION OF TRADING

The board (the ''Board'') of directors (the ''Directors'') of Yestar Healthcare Holdings Company Limited (the ''Company'') hereby announces that, at the request of the Company, trading in Company's US$200 million 6.9% senior notes due 2021 senior notes on The Stock Exchange of Hong Kong Limited will be suspended with effect from 9 : 00 a.m. on 1 April 2021 pending the publication of the annual results of the Company for the year ended 31 December 2020.

By Order of the Board

Yestar Healthcare Holdings Company Limited

Hartono James

Chairman, CEO and Executive Director

31 March 2021

As at the date of this announcement, the executive Directors are Mr. Hartono James, Ms. Wang Ying, Ms. Wang Hong and Ms. Liao Changxiang; the independent non-executive Directors are Dr. Hu Yiming, Mr. Karsono Tirtamarta (Kwee Yoe Chiang) and Mr. Sutikno Liky.

Attachments

  • Original document
  • Permalink

Disclaimer

Yestar Healthcare Holdings Co. Ltd. published this content on 01 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2021 01:29:05 UTC.